The number of late-night pharmacies in England has fallen more than 90 per cent in three years, according to an analysis of NHS data, raising fresh concerns about patient access to out-of-hours care.
The national conversation around prescription drug pricing is back in full force. From the recent Most Favored Nation (MFN) executive order to President Trump's letter urging pharmaceutical companies to offer direct-to-consumer (DTC) pricing for brand medications, it's clear we're at a pivotal moment for American healthcare. It's a moment that demands more than just rhetoric; it demands innovation, pragmatism, and above all, deep collaboration across the industry.
CVS and Walgreens, the country's two largest pharmacy chains, are for now clamping down on offering Covid vaccines in more than a dozen states, even to people who meet newly restricted criteria from the Food and Drug Administration. On Thursday, Amy Thibault, a spokeswoman for CVS, said the vaccine was not available at pharmacies in 16 states, citing the current regulatory environment and emphasizing that the list could change. She did not provide an explanation for the change.
